CME Information
Provider Statement: This continuing medical education activity is provided by 
.
Support Statement: This activity is supported by an educational grants from Takeda Pharmaceuticals U.S.A., Inc. and Novo Nordisk, Inc.
Target Audience: The intended audience for this activity is internal medicine physicians, general practice physicians, family practice physicians, endocrinologists, cardiologists, nurse practitioners, physician assistants, and other health care professionals involved in the treatment of patients with overweight or obesity.
Learning Objectives: Upon successful completion of this educational, participants should be better able to:
- Describe the pathophysiological, psychosocial, and environmental factors that contribute toward obesity’s definition as a disease.
- Apply clinical practice guidelines to identify, counsel, and treat patients with overweight or obesity.
- Utilize comprehensive therapeutic modalities, including patient engagement and activation tools, to induce and maintain weight loss in patients with overweight and obesity.
- Assess the clinical benefits, mechanisms, and safety profiles of new and emerging anti-obesity medications when evaluating the most appropriate therapeutic interventions for patients with overweight or obesity.
- Incorporate effective lifestyle modifications and motivational strategies in the management of overweight and obesity.
Chief Medical Editor
Robert F. Kushner, MD, MS, FACP, FTOS
Professor of Medicine
Northwestern University
Feinberg School of Medicine
Chicago, IL
Editorial Board:
Scott Kahan, MD, MPH, FTOS
Director, National Center for Weight and Wellness
Medical Director, Strategies to Overcome and Prevent (STOP) Obesity Alliance
George Washington University Milken Institute School of Public Health
Washington, DC
Donna H. Ryan, MD, FACP, FTOS
Professor Emerita
Pennington Biomedical Research Center
Louisiana State University
Baton Rouge, LA
Christopher D. Still, DO, FACN, FACP
Medical Director, Center for Weight Management
Director, Geisinger Obesity Institute
Associate, Department of Gastroenterology and Nutrition
Geisinger Health Care System
Danville, PA
Holly R. Wyatt, MD
Associate Professor of Medicine
Division of Endocrinology, Metabolism and Diabetes
Associate Director, Anschutz Health and Wellness Center
University of Colorado
Aurora, CO
Reviewer
Ronald Codario, MD, FACP, FNLA, RPVI, CHCP (Recertification review on 08/31/2017)
Accreditation:
Vindico Medical Education is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
Credit Designation:
Vindico Medical Education designates this enduring material for a maximum of 1.25 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Nurse practitioners can apply for AMA PRA Category 1 Credit(s)™ through the American Academy of Nurse Practitioners (AANP). AANP will accept AMA PRA Category 1 Credit(s)™ from organizations accredited by Accreditation Council for Continuing Medical Education. Nurse practitioners can also apply for credit through their state boards.
American Academy of Physician Assistants (AAPA) accepts certificates of participation for educational activities certifi ed for AMA PRA Category 1 Credit(s)™ from organizations accredited by the ACCME. Physician assistants may receive a maximum of 1.25 hours credit for completing this program.
This enduring material was originally approved for 1 year from the date of original release, October 1, 2015 to October 1, 2016. It has since been recertified for two additional years and will now expire on September 12, 2018.
How To Participate in this Activity and Obtain CME Credit:
To participate in this CME activity, you must read the objectives and articles, complete the CME posttest, and evaluation. Provide only one (1) correct answer for each question. A satisfactory score is defined as answering 70% of the posttest questions correctly.
Upon receipt of the completed materials, if a satisfactory score on the posttest is achieved, Vindico Medical Education will issue an AMA PRA Category 1 Credit(s)™ certificate.
Disclosures:
In accordance with the Accreditation Council for Continuing Medical Education’s Standards for Commercial Support, all CME providers are required to disclose to the activity audience the relevant financial relationships of the planners, teachers, and authors involved in the development of CME content. An individual has a relevant financial relationship if he or she has a financial relationship in any amount occurring in the last 12 months with a commercial interest whose products or services are discussed in the CME activity content over which the individual has control.
Faculty Members report the following relationship(s) which are accurate at the time of original content release (October 1, 2015):
Robert F. Kushner, MD, MS, FACP, FTOS
Consulting Fees: Novo Nordisk, Inc., Retrofit, Takeda Pharmaceuticals, Weight Watchers, Zafgen
Contracted Research: Aspire Bariatrics, Weight Watchers
Scott Kahan, MD, MPH, FTOS
Royalty (Textbooks): Johns Hopkins University Press, Lippincott Williams & Wilkins, Wolters Kluwer
Consulting Fees: Eisai Inc., Novo Nordisk, Inc., Takeda Pharmaceuticals, Vivus, Inc.
Speakers Bureau: Eisai, Inc., Novo Nordisk, Inc., Takeda Pharmaceuticals, Vivus, Inc.
Board of Directors: American Board of Obesity Medicine
Donna H. Ryan, MD, FACP, FTOS
Consulting Fees: Novo Nordisk, Inc., Pfizer, Real Appeal, Takeda Pharmaceuticals, Vivus, Inc.
Speakers Bureau: Eisai, Inc., Novo Nordisk, Inc., Takeda Pharmaceuticals, Vivus, Inc.
Ownership Interest Stock: Scientific Intake, Tulip
Christopher D. Still, DO, FACN, FACP
Consulting Fees: Eisai, Inc., Novo Nordisk, Inc., Takeda Pharmaceuticals, Vivus, Inc.
Speakers Bureau: Eisai, Inc., Novo Nordisk, Inc., Takeda Pharmaceuticals, Vivus, Inc.
Holly R. Wyatt, MD
Royalty: UpToDate, Inc.
Intellectual Property Rights/Patent Holder: Energy Gap
Consulting Fees: Wellspring Pharmaceutical
Contracted Research: American Beverage Association, GI Dynamics, Novo Nordisk, Inc.
Ownership Interest Stock: Active Planet
Board Member/Advisory Panel: Atkins, Eisai, Inc., Retrofit, Takeda Pharmaceuticals, Vivus, Inc.
Author: Rodale
Reviewers report the following relationship(s):
Ronald Codario, Jr., MD
No relevant financial relationships to disclose.
Ronald Codario, MD, FACP, FNLA, RPVI, CHCP
No relevant financial relationships to disclose.
Medical Writer reports the following relationship(s):
Valerie Zimmerman, PhD
No relevant financial relationships to disclose.
Vindico Medical Education staff report the following relationship(s):
No relevant financial relationships to disclose.
Signed disclosures are on file at Vindico Medical Education, Office of Medical Affairs and Compliance.
Unlabeled and Investigational Usage:
The audience is advised that this continuing medical education activity may contain references to unlabeled uses of US Food and Drug Administration (FDA)-approved products or to products not approved by the FDA for use in the United States. The faculty members have been made aware of their obligation to disclose such usage. All activity participants will be informed if any speakers/authors intend to discuss either non-FDA approved or investigational use of products/devices.
Copyright Statement:
Created and published by Vindico Medical Education, 6900 Grove Road, Building 100, Thorofare, NJ 08086-9447. Telephone: 856-994-9400; Fax: 856-384-6680. Printed in the USA. Copyright © 2015 Vindico Medical Education. All rights reserved. No part of this publication may be reproduced without written permission from the publisher. The material presented at or in any of Vindico Medical Education continuing medical education activities does not necessarily reflect the views and opinions of Vindico Medical Education. Neither Vindico Medical Education nor the faculty endorse or recommend any techniques, commercial products, or manufacturers. The faculty/authors may discuss the use of materials and/or products that have not yet been approved by the US Food and Drug Administration. All readers and continuing education participants should verify all information before treating patients or utilizing any product.
CME Questions?
Contact us at cme@vindicoCME.com